Literature DB >> 29581357

Cutting Edge: Imbalanced Cation Homeostasis in MAGT1-Deficient B Cells Dysregulates B Cell Development and Signaling in Mice.

Sanjeev Kiran Gotru1,2, Jesus Gil-Pulido1, Niklas Beyersdorf3, Andreas Diefenbach4, Isabelle C Becker1,2, Timo Vögtle1,2, Katharina Remer1,2, Vladimir Chubanov5, Thomas Gudermann5, Heike M Hermanns6, Bernhard Nieswandt1,2, Thomas Kerkau3, Alma Zernecke1, Attila Braun7,2.   

Abstract

Cation homeostasis, in relation to various immune-suppressive diseases, is a novel field of investigation. Recently, patients with a loss-of-function mutation in magnesium transporter 1 (MAGT1) were reported to present a dysregulated Mg2+ homeostasis in T lymphocytes. Using Magt1-knockout mice (Magt1-/y ), we show that Mg2+ homeostasis was impaired in Magt1-/y B cells and Ca2+ influx was increased after BCR stimulation, whereas T and NK cell function was unaffected. Consequently, mutant B cells displayed an increased phosphorylation of BCR-related proteins differentially affecting protein kinase C activation. These in vitro findings translated into increased frequencies of CD19+ B cells and marginal zone B cells and decreased frequencies of plasma cells among CD45+ splenocytes in vivo. Altogether, our study demonstrates for the first time, to our knowledge, that abolished MAGT1 function causes imbalanced cation homeostasis and developmental responses in B cells. Therefore, this study might contribute to a further understanding of B cell-related pathologies.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29581357     DOI: 10.4049/jimmunol.1701467

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Diversity of XMEN Disease: Description of 2 Novel Variants and Analysis of the Lymphocyte Phenotype.

Authors:  Elizabeth M Klinken; Paul E Gray; Bethany Pillay; Lisa Worley; Emily S J Edwards; Kathryn Payne; Bruce Bennetts; Dorothy Hung; Ben A Wood; Jonathan J Chan; Glenn M Marshall; Richard Mitchell; Gulbu Uzel; Cindy S Ma; Stuart G Tangye; Andrew McLean-Tooke
Journal:  J Clin Immunol       Date:  2019-12-21       Impact factor: 8.317

Review 2.  An Update on XMEN Disease.

Authors:  Juan C Ravell; Samuel D Chauvin; Tingyan He; Michael Lenardo
Journal:  J Clin Immunol       Date:  2020-05-26       Impact factor: 8.317

Review 3.  Ion Channels and Transporters in Inflammation: Special Focus on TRP Channels and TRPC6.

Authors:  Giuseppe A Ramirez; Lavinia A Coletto; Clara Sciorati; Enrica P Bozzolo; Paolo Manunta; Patrizia Rovere-Querini; Angelo A Manfredi
Journal:  Cells       Date:  2018-07-04       Impact factor: 6.600

Review 4.  Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.

Authors:  Sylvain Latour; Sarah Winter
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

Review 5.  Beyond the CRAC: Diversification of ion signaling in B cells.

Authors:  Trisha Mahtani; Bebhinn Treanor
Journal:  Immunol Rev       Date:  2019-09       Impact factor: 12.988

6.  Novel MAGT1 Mutation Found in the First Chinese XMEN in Hong Kong.

Authors:  Elaine Yuen Ling Au; Edmund Kwok Kwan Tung; Ricky Wai Ki Ip; Philip Hei Li
Journal:  Case Reports Immunol       Date:  2022-02-14

7.  Further Delineation of the Spectrum of XMEN Disease in Six Chinese Pediatric Patients.

Authors:  Xiaomin Peng; Yi Lu; Huijun Wang; Bingbing Wu; Mingyu Gan; Suzhen Xu; Deyi Zhuang; Jianshe Wang; Jinqiao Sun; Xiaochuan Wang; Wenhao Zhou
Journal:  Front Genet       Date:  2022-01-25       Impact factor: 4.599

8.  Identification of a novel MAGT1 mutation supports a diagnosis of XMEN disease.

Authors:  Christopher M Watson; Fatima Nadat; Sammiya Ahmed; Laura A Crinnion; Sean O'Riordan; Clive Carter; Sinisa Savic
Journal:  Genes Immun       Date:  2022-03-09       Impact factor: 4.248

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.